| Bioactivity | Trachelogenin ((-)-Trachelogenin) is an HCV entry inhibitor without genotype specificity, and with low cytotoxicity. Trachelogenin inhibits HCVcc infection and HCVpp cell entry in a dose-dependent manner with an IC50 of 0.325 and 0.259 μg/mL in HCVcc and HCVpp models, respectively. Trachelogenin exhibits effective antiviral, anti-inflammatory and analgesic effects[1]. |
| Name | Trachelogenin |
| CAS | 34209-69-3 |
| Formula | C21H24O7 |
| Molar Mass | 388.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
Trachelogenin
CAS: 34209-69-3 F: C21H24O7 W: 388.41
Trachelogenin ((-)-Trachelogenin) is an HCV entry inhibitor without genotype specificity, and with low cytotoxicity. Tra
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.